Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review. Issue 8 (August 2012)

• Record Type: Journal Article
• Authors: Al-Allak, Asmaa; Lewis, Paul D; Bertelli, Gianfilippo
• Is Part Of: Expert review of anticancer therapy. Volume 12:Issue 8(2012)
• Page Start: 1033
• Page End: 1043
• Publication Date: 2012-08
• Subjects: Adjuvant! Online -- breast cancer -- MammaPrint -- Nottingham Prognostic Index -- Oncotype DX -- PAM50 -- PREDICT -- St Gallen Consensus Conference -- TNM; Cancer -- Treatment -- Periodicals; 616.99406
• DOI: 10.1586/era.12.83
• Languages: English
• ISSNs: 1473-7140

Abstract

Breast cancer remains the most common type of cancer affecting women worldwide with an estimated lifetime risk of 1:8. With developments in adjuvant treatment and the identification of breast cancer subtypes, rising expectation of 'personalized' and 'targeted' therapy, decisions on systemic therapy have become increasingly more difficult. In a bid to assist clinicians in correctly selecting patients in whom systemic adjuvant therapy would be of most benefit, a number of decision-making tools have been developed. In this article, the authors will review some of these tools, explore how they were developed and assess the impact they have had on daily clinical practice.